Medtronic's MiniMed™ 780G System^ Earns Prestigious Award, Promises Advancements in Diabetes Care for Australians^1,2

Medtronic has solidified its place as a global leader in healthcare technology with the recognition of its MiniMed™ 780G automated insulin delivery system in Fast Company's 2024 World Changing Ideas Awards. This honour, awarded in the Best World-Changing Idea, North America category, highlights Medtronic's commitment to transforming diabetes care—an advancement that holds significant promise for Australians managing diabetes.

Que Dallara, EVP and President of Medtronic Diabetes, expressed pride in this achievement, emphasizing the company's mission to simplify diabetes care and reduce the disease's mental burden. Ali Dianaty, Senior VP of Product Innovation and Operations, highlighted the collaborative effort behind the MiniMed™ 780G, designed to adapt to each user's unique needs and improve their quality of life.

Medtronic continues to lead the charge in healthcare innovation, demonstrating bold thinking and actions to address the world's most challenging health problems. Australians can expect to benefit from these advancements as Medtronic's cutting-edge technology becomes increasingly available, promising better health outcomes and improved daily management for those living with diabetes.